Abstract
Little is known about how people’s lives are influenced when going from a 50% risk status of Huntington’s disease (HD) to no risk after performing predictive testing. In this study, 20 interviews were conducted to explore the long-term (> 5 years) experiences after receiving predictive test results as a non-carrier of HD. The results showed a broad variety of both positive and negative reactions. The most prominent positive reaction reported was feelings of relief and gratitude, of not carrying the HD mutation for themselves and for their children. Also, the non-carrier status promoted in some individuals’ significant life changes such as a wishing to have (more) children, pursuing a career or breaking up from an unhappy relationship. However, negative reactions on their psychological well-being were also described. Some had experienced psychological pressure of needing to do something extraordinary in their lives; others expressed feelings of guilt towards affected or untested siblings, resulting in sadness or clinical depression. The new genetic risk status could generate a need of re-orientation, a process that for some persons took several years to accomplish. The results of the present study show the importance of offering long-term post-result counselling for non-carriers in order to deal with the psychological consequences that may follow predictive testing.
Similar content being viewed by others
References
Almqvist, E., Robins Wahlin, T.-B., Haegermark, A., Lundin, A., Winblad, B., & Anvret, M. (1994). Problems within the sibship experienced during predictive testing for Huntington’s disease. Abstract from 4th European meeting on psychosocial aspects of genetics, Heidelberg University, 12th–14th of September, 1994.
Almqvist, E. W., Bloch, M., Brinkman, R., Craufurd, D., Hayden, M. R., & on behalf on an international Huntington disease collaborative group. (1999). A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. American Journal of Human Genetics, 64, 1293–1304.
Almqvist, E. W., Brinkman, R., Wiggins, S., & Hayden, M. R. (2003). Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington’s disease. Clinical Genetics, 64, 300–309.
Codori, A.-M., & Brandt, J. (1994). Psychological costs and benefits of predictive testing for Huntington’s disease. American Journal of Medical Genetics, 54, 174–184.
Creswell, J. W., & Poth, C. N. (2017). Qualitative inquiry and research design: choosing among five approaches (4th ed.). Los Angeles: Sage Publications.
Crozier, S., Robertson, N., & Dale, M. (2015). The psychological impact of predictive genetic testing for Huntington’s disease: a systematic review of the literature. Journal of Genetic Counseling, 24, 29–39. https://doi.org/10.1007/s10897-014-9755-y.
Decruyenaere, M., Evers-Kiebooms, G., Cloostermans, T., Boogaerts, A., Demyttenaere, K., Dom, R., & Fryns, J. P. (2003). Psychological distress in the 5-year period after predictive testing for Huntington’s disease. European Journal of Human Genetics, 11, 30–38. https://doi.org/10.1038/sj.ejhg.5200913.
Duncan, R. E., Gillam, L., Savulescu, J., Williamson, R., Rogers, J. G., & Delatycki, M. B. (2007). “Holding your breath”: interviews with young people who have undergone predictive genetic testing for Huntington disease. American Journal of Medical Genetics A, 143, 1984–1989. https://doi.org/10.1002/ajmg.a.31720.
Duncan, R. E., Gillam, L., Savulescu, J., Williamson, R., Rogers, J. G., & Delatycki, M. B. (2008). “You’re one of us now”: young people describe their experience of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP). American Journal of Medical Genetics Part C (Seminars in Medical Genetics), 148C, 47–55. https://doi.org/10.1002/ajmg.c.30158.
Forrest Keenan, K., McKee, L., & Miedzybrodzka, Z. (2015). Help or hindrance: young people’s experiences of predictive testing for Huntington’s disease. Clinical Genetics, 87, 563–569. https://doi.org/10.1111/cge.12439.
Gargiulo, M., Lejeune, S., Tanguy, M.-L., Lahlou-Laforêt, K., Faudet, A., Cohen, D., Feingold, J., & Durr, A. (2009). Long-term outcome of presymptomatic testing in Huntington disease. European Journal of Human Genetics, 17, 165–171. https://doi.org/10.1038/ejhg.2008.146.
Gillies, J., & Neimeyer, R. A. (2006). Loss, grief, and the search for significance: toward a model of meaning reconstruction in bereavement. Journal of Constructivist Psychology, 19(1), 31–65. https://doi.org/10.1080/10720530500311182.
Graneheim, U. H., & Lundman, B. (2004). Qualitative content analysis in nursing research: concept, procedures and measures to achieve trustworthiness. Nurse Education Today, 24, 105–112. https://doi.org/10.1016/j.nedt.2003.10.001.
Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K., Wallace, M. R., Sakaguchi, A. Y., Young, A. B., Shoulson, I., Bonilla, E., & Martin, J. B. (1983). A polymorphic DNA marker genetically linked to Huntington’s disease. Nature, 306, 234–238.
Hagberg, A., Bui, T.-H., & Winnberg, E. (2011). More appreciation of life or regretting the test? Experiences of living as a mutation carrier of Huntington’s disease. Journal of Genetic Counseling, 20, 70–79. https://doi.org/10.1007/s10897-010-9329-6.
Hayden, M. R. (1981). Huntington’s chorea. Berlin: Springer Verlag.
Huggins, M., Bloch, M., Adam, S., Suchowersky, O., Trew, M., Klimek, M., et al. (1992). Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk. American Journal of Medical Genetics, 42, 508–515.
Hutson, S. P., Hall, J. M., & Pack, F. L. (2015). Survivor guilt. Analyzing the concept and its contexts. Advances in Nursing Science, 38(1), 20–33. https://doi.org/10.1097/ANS.0000000000000058.
Larsson, M. U., Luszcz, M. A., Bui, T.-H., & Robins Wahlin, T.-B. (2006). Depression and suicidal ideation after predictive testing for Huntington’s disease: a two-year follow up study. Journal of Genetic Counseling, 15(5), 361–374. https://doi.org/10.1007/s10897-006-9027-6.
Licklederer, C., Wolff, G., & Barth, J. (2008). Mental health and quality of life after genetic testing for Huntington disease: a long-term effect study in Germany. American Journal of Medical Genetics Part A, 146A, 2078–2085. https://doi.org/10.1002/ajmg.a.32423.
Lilja Andersson, P., Juth, N., Petersen, Å., Graff, C., & Edberg, A.-K. (2012). Ethical aspects of undergoing a predictive testing for Huntington’s disease. Nursing Ethics, 20(2), 189–199.
MacLeod, R., Tibben, A., Frontali, M., Evers-Kiebooms, G., Jones, A., Matinez-Descales, A., et al. (2013). Recommendations for the predictive genetic test in Huntington’s disease. Clinical Genetics, 83, 221–231. https://doi.org/10.1111/j.1399-0004.2012.01900.x.
Richards, F. (2004). Couples’ experiences of predictive testing and living with the risk or reality of Huntington disease: a qualitative study. American Journal of Medical Genetics, 126A, 170–182. https://doi.org/10.1002/ajmg.a.20583.
Robins Wahlin, T.-B., Lundin, A., Bäckman, L., Almqvist, E., Haegermark, A., Winblad, B., et al. (1997). Reactions to predictive testing in Huntington disease: case reports of coping with a new genetic status. American Journal of Medical Genetics, 73, 356–365.
Tassicker, R. J. (2005). Psychodynamic theory and counseling in predictive testing for Huntington’s disease. Journal of Genetic Counseling, 14(2), 99–107. https://doi.org/10.1007/s10897-005-4066-y.
The Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosome. Cell, 72, 971–983.
Tibben, A., Timman, R., Bannink, E. C., & Duivenvoorden, H. J. (1997). Three-year follow-up after presymptomatic testing for Huntington’s disease in tested individuals and partners. Health Psychology, 16(1), 20–35.
Timman, R., Roos, R., Maat-Kievit, A., & Tibben, A. (2004). Adverse effects of predictive testing for Huntington disease underestimated: long-term effects 7-10 years after the test. Health Psychology, 23(2), 189–197. https://doi.org/10.1037/0278-6133.23.2.189.
Valverde, K. D. (2006). Why me? Why not me? Journal of Genetic Counseling, 15(6), 461–463. https://doi.org/10.1007/s10897-006-9055-2.
Wiggins, S., Whyte, P., Huggins, M., Adam, S., Theilmann, J., Bloch, M., Sheps, S. B., Schechter, M. T., & Hayden, M. R. (1992). The psychological consequences of predictive testing for Huntington’s disease. New England Journal of Medicine, 327, 1401–1405.
Williams, J. K., Schutte, D. L., Evers, C., & Holkup, P. A. (2000). Redefinition: coping with normal results from predictive gene testing for neurodegenerative disorders. Research in Nursing & Health, 23, 260–269.
Acknowledgments
We are grateful to all participants for participating in this study. We thank Dr. The-Hung Bui at the Department of Clinical Genetics, Karolinska University Hospital, Stockholm, for the approval of contacting the participants. This work was supported by The Swedish Association for Persons with Neurological Disabilities.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors Elisabeth Winnberg, Ulrika Winnberg, Lilian Pohlkamp and Anette Hagberg declare that they have no conflict of interest.
Human Studies and Informed Consent
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
Animal Studies
No animal studies were carried out by the authors for this article.
Electronic Supplementary Material
ESM 1
(DOCX 14 kb)
Rights and permissions
About this article
Cite this article
Winnberg, E., Winnberg, U., Pohlkamp, L. et al. What to Do with a Second Chance in Life? Long-Term Experiences of Non-carriers of Huntington’s Disease. J Genet Counsel 27, 1438–1446 (2018). https://doi.org/10.1007/s10897-018-0257-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-018-0257-1